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Accuracy of ICD-9 Coding for Sickle Cell
Disease (SCD) in Children and Adolescents:

Results from the Georgia (GA) RuSH Surveillance Project
Peter A Lane MD, Rodney Theodore MPH, Mei Zhou MS, Angela Snyder PhD
R E S E A R C H O B J E C TI V E

To study the accuracy of using ICD-9 codes within administrative claims data to identify individuals
with Sickle Cell Disease (SCD).

Retrospective study to evaluate the accuracy of the Registry and Surveillance for Hemoglobinopathies
(RuSH) case definition in identifying true cases of SCD in administrative datasets. Probable cases
required identification of ≥ 2 encounters with a SCD ICD-9 code (282.60-282.69; 282.41-282.42) plus
≥ 1 encounter with an ICD-9 or CPT code from a predetermined list of SCD-associated treatments,
procedures, and complications (SCD-TPC).
Table 1. SCD-associated treatments, procedures, and
complications added to the RuSH case definition
SCD-associated treatments
SCD-associated complications
Parenteral analgesics (Morphine, meperidine,
hydromorphone, ketorolac, butorphanol)
Iron Chelators (deferasirox, deferoxamine)

Chronic Renal failure/Proteinuria
Pneumonia, acute chest syndrome
Pulmonary hypertension

Erythropoietin

Stroke (ischemic or hemorrhagic), TIA, seizures

Folic acid

Intracranial bleeding
Priapism
Iron overload

SCD-associated procedures

Gallstones/cholelithiasis, cholecystitis

Red cell transfusion

Avascular necrosis

Red cell exchange

Cholecystectomy

Retinal disease
Splenomegaly, splenic sequestration, hypersplenism
Leg ulcers

Transcranial Doppler

Dactylitis

Splenectomy

Osteomyelitis

Cases identified in administrative data were then compared to laboratory and clinical chart review
data from Children’s Healthcare of Atlanta (CHOA) to report on the accuracy of this case definition.
Specific objectives were to evaluate accuracy in terms of 1) the number of SCD-coded encounters
for each individual, 2) the addition of SCD-TPC to the case definition, and 3) the length of the
surveillance period (1 versus 5 years of data). Cases with inadequate clinical data to confirm or
exclude SCD were categorized as indeterminate.

PO PU LATI O N S TU DI E D

A total of 1,998 children and adolescents with ≥ 1 encounter with a SCD ICD-9 code in three
administrative datasets: Georgia Medicaid, CHIP, and State Health Benefit Plan claims data from
2004-2008 who were seen at least once at a CHOA facility and had medical records available for
review.

This work was supported by Cooperative Agreement Numbers U50DD00582 and
U50DD001010, funded by the Centers for Disease Control and Prevention. Its
contents are solely the responsibility of the authors and do not necessarily represent
the official views of the Centers for Disease Control and Prevention
or the Department of Health and Human Services.

SCD was confirmed in 1,763 (88.2%), excluded in 196 (9.8%), and indeterminate in 39 (2.0%) of the 1,998 children.

Table 2. Relationship between number of encounters with SCD ICD-9 codes and SCD status determined by review of medical
records for 5 year (2004-2008) versus 1 year (2008) surveillance period

S TU DY DE S I GN

Hydroxyurea

P RI N C I PA L F I N D I N GS

Surveillance
period (yr)

SCD ICD-9
codes

Patients

SCD confirmed

SCD excluded

Indeterminate

5

≥1

1,998

1,763 (88.2%)

196 (9.8%)

39 (2.0%)

1

≥1

1,454

1,386 (95.3%)

57 (3.7%)

11 (0.8%)

5

≥2

1,851

1,735 (93.7%)

96 (5.2%)

20 (1.1%)

1

≥2

1,373

1,333 (97.1%)

33 (2.4%)

7 (0.5%)

5

≥3

1,746

1,693 (97.0%)

46 (2.6%)

7 (0.4%)

1

≥3

1,248

1,231 (98.6%)

14 (1.1%)

3 (0.2%)

P-value*
<0.01
<0.01
<0.01

*P-values calculated by chi-square tests. P-value tests whether the proportion of those confirmed to have SCD using 5 years of data
differs significantly from the proportion of those confirmed to have SCD using 1 year of data (i.e. compares 88.2% to 95.3%).

The likelihood of having SCD significantly increased with an increasing number of SCD ICD-9 codes during both time periods. The 1-year period
had better accuracy, but more missed cases. For the 5-year surveillance period, the accuracy of ≥ 2 SCD ICD-coded encounters (93.7%) increased
to (97.0%) with the addition of ≥ 1 encounter with SCD-TPC, but the number of missed cases increased from 28 (1.6%) to 251 (14.2%).

Table 3. Effect of number of SCD ICD-9 codes and inclusion
of ICD-9 and CPT codes for SCD-associated treatments,
procedures, and complication to RuSH surveillance case
definition (2004-2008)
Case Definition

Patients
(n)

≥ 1 SCD ICD-9 code

1,998

≥ 2 SCD ICD-9 codes

1,851

≥ 2 SCD ICD-9 codes &
≥ 1 ICD-9/CPT code for
SCD TPC
≥ 3 SCD ICD-9 codes

SCD
confirmed
1,763
(88.2%)
1,735
(93.7%)

SCD cases
missed
0
28 (1.6%)

1,558

1,512
(97.0%)

251 (14.2%)

1,746

1,693
(97.0%)

70 (4.0%)

CONCLUSION

Use of administrative claims data to identify children and adolescents with
SCD based on ICD-9 coding can be useful to health services researchers,
but it has some limitations depending on the research question. Accuracy of
identification correlated directly with the number of SCD-coded encounters
and indirectly with the length of the surveillance period. The addition of
≥ 1 encounter with SCD-TPC to a case definition of ≥ 2 encounters with
SCD ICD-9 codes minimally improved specificity but resulted in a large
number of missed cases, more than the simpler definition of ≥ 3 SCDcoded encounters.

I MP L I C AT I O N S F O R P O L I C Y O R P RA C T I C E

Health services and outcomes research in SCD has been limited by inadequate population-based surveillance and reliance on ICD-9 codes to
identify individuals with SCD. This study supports an administrative case definition that includes 3 or more separate ICD-9 codes in order to identify
SCD with a high degree of accuracy and suggests it can be useful to assess quality of care. However, using administrative data, by design, excludes
individuals who have less health care utilization and are therefore less costly. Those limitations must be weighed against the benefits of using the
data in future health services research.
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